| scholarly article | Q13442814 |
| P50 | author | Lisa M Ebert | Q57415932 |
| Craig Gedye | Q58328980 | ||
| P2093 | author name string | Jonathan Cebon | |
| Weisan Chen | |||
| Ian D Davis | |||
| Duncan MacGregor | |||
| Bee Shin Tan | |||
| Judy Browning | |||
| Sarah E Russell | |||
| Sweet Ping Ng | |||
| Denis Moss | |||
| Suzanne Svobodova | |||
| Naomi Kirkpatrick | |||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 3001-3009 | |
| P577 | publication date | 2008-04-01 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | The regulatory T cell-associated transcription factor FoxP3 is expressed by tumor cells | |
| P478 | volume | 68 |
| Q33423855 | A central role for Foxp3+ regulatory T cells in K-Ras-driven lung tumorigenesis |
| Q37390262 | A fork in the path: Developing therapeutic inroads with FoxO proteins |
| Q64240589 | Aberrant mRNA splicing generates oncogenic RNA isoforms and contributes to the development and progression of cholangiocarcinoma |
| Q38779090 | Activation-dependent mitochondrial translocation of Foxp3 in human hepatocytes |
| Q55495606 | Alternative Splicing of FOXP3-Virtue and Vice. |
| Q37045312 | Amelioration of autoimmune arthritis by adoptive transfer of Foxp3-expressing regulatory B cells is associated with the Treg/Th17 cell balance |
| Q34445730 | Analysis of FoxP3+ T-regulatory cells and CD8+ T-cells in ovarian carcinoma: location and tumor infiltration patterns are key prognostic markers |
| Q40682048 | Both tumour cells and infiltrating T-cells in equine sarcoids express FOXP3 associated with an immune-supressed cytokine microenvironment |
| Q44705573 | CD4 helper T cells, CD8 cytotoxic T cells, and FOXP3(+) regulatory T cells with respect to lethal prostate cancer |
| Q42502215 | CD44 induces FOXP3 expression and is related with favorable outcome in breast carcinoma. |
| Q80945689 | Cancer Vaccines 2007. Cancer and HIV Vaccines: Shared Lessons. October 4-6, 2007, New York, USA. Abstracts |
| Q38240871 | Cholangiocarcinoma with respect to IgG4 Reaction |
| Q86360571 | Circulating autoantibody to FOXP3 may be a potential biomarker for esophageal squamous cell carcinoma |
| Q37071395 | Clever cancer strategies with FoxO transcription factors |
| Q36230689 | Clinical implications and characteristics of factor forkhead box protein 3 in gastric cancer |
| Q39167643 | Clinical significance of FOXP3 expression in human gliomas |
| Q92002867 | Dawn of Monitoring Regulatory T Cells in (Pre-)clinical Studies: Their Relevance Is Slowly Recognised |
| Q53440458 | Downregulation of FOXP2 promoter human hepatocellular carcinoma cell invasion. |
| Q89457673 | Durable tumor regression in highly refractory metastatic KIT/PDGFRA wild-type GIST following treatment with nivolumab |
| Q42497512 | Effects of ultraviolet radiation exposure on FOXP3+ infiltration in cutaneous squamous cell carcinoma and basal cell carcinoma |
| Q35479432 | Endogenous FOXP3 inhibits cell proliferation, migration and invasion in glioma cells |
| Q84627462 | Erythropoietin, forkhead proteins, and oxidative injury: biomarkers and biology |
| Q34354653 | Expression and DNA methylation of TNF, IFNG and FOXP3 in colorectal cancer and their prognostic significance. |
| Q39351950 | Expression of Forkhead box P3 in tumour cells causes immunoregulatory function of signet ring cell carcinoma of the stomach |
| Q53245210 | Expression of FoxP3 protein plays a key role in thyroid tumors in children. |
| Q34575227 | Expression of Foxp3 in colorectal cancer but not in Treg cells correlates with disease progression in patients with colorectal cancer |
| Q39067997 | Expression of Foxp3, CD25 and IL-2 in the B16F10 cancer cell line and melanoma is correlated with tumor growth in mice |
| Q36464531 | Expression of tumoral FOXP3 in gastric adenocarcinoma is associated with favorable clinicopathological variables and related with Hippo pathway |
| Q33872907 | FOXP3 Allelic Variants and Haplotype Structures Are Associated with Aggressive Breast Cancer Subtypes |
| Q40042902 | FOXP3 Is a HCC suppressor gene and Acts through regulating the TGF-β/Smad2/3 signaling pathway |
| Q37216338 | FOXP3 and its partners: structural and biochemical insights into the regulation of FOXP3 activity |
| Q35845395 | FOXP3 as an X-linked tumor suppressor |
| Q34333197 | FOXP3 expression and clinical characteristics of hepatocellular carcinoma |
| Q38016804 | FOXP3 expression in tumor cells and implications for cancer progression. |
| Q34660488 | FOXP3 expression in tumor cells and tumor-infiltrating lymphocytes is associated with breast cancer prognosis |
| Q55001270 | FOXP3 expression is modulated by TGF‑β1/NOTCH1 pathway in human melanoma. |
| Q37033496 | FOXP3 gene polymorphism is associated with hepatitis B-related hepatocellular carcinoma in China |
| Q43517558 | FOXP3 is not mutated in human melanoma |
| Q24567994 | FOXP3 over-expression inhibits melanoma tumorigenesis via effects on proliferation and apoptosis |
| Q37273633 | FOXP3 regulates sensitivity of cancer cells to irradiation by transcriptional repression of BRCA1 |
| Q43474250 | FOXP3+ cell density in primary tumor has no prognostic impact in patients with cutaneous malignant melanoma |
| Q84278927 | FOXP3+CD25- tumor cells with regulatory function in Sézary syndrome |
| Q39120137 | FOXP3, a novel glioblastoma oncosuppressor, affects proliferation and migration |
| Q44593639 | FOXP3-positive regulatory T lymphocytes and epithelial FOXP3 expression in synchronous normal, ductal carcinoma in situ, and invasive cancer of the breast |
| Q27003398 | FOXP3: genetic and epigenetic implications for autoimmunity |
| Q91972582 | Forkhead box P3 gene silencing inhibits the expression of chemokines and chemokine receptors associated with cell growth, migration, and apoptosis in hepatocellular carcinoma cells |
| Q37611662 | Forkhead box P3 regulates ARHGAP15 expression and affects migration of glioma cells through the Rac1 signaling pathway |
| Q38172563 | Forkhead box P3: the peacekeeper of the immune system. |
| Q38844406 | FoxP3 in papillary thyroid carcinoma induces NIS repression through activation of the TGF-β1/Smad signaling pathway |
| Q37009831 | FoxP3: a life beyond regulatory T cells |
| Q38234076 | Foxp3 expression in T regulatory cells and other cell lineages |
| Q34271151 | Foxp3 expression in macrophages associated with RENCA tumors in mice. |
| Q39547224 | Foxp3 expression in melanoma cells as a possible mechanism of resistance to immune destruction |
| Q33843619 | Foxp3 positive regulatory T cells: a functional regulation by the E3 ubiquitin ligase Itch |
| Q38772804 | Gonadotropin and tumorigenesis: Direct and indirect effects on inflammatory and immunosuppressive mediators and invasion |
| Q37650692 | High FoxP3 expression in tumour cells predicts better survival in gastric cancer and its role in tumour microenvironment |
| Q54513849 | High expression of Foxp3, IL-23p19 and survivin mRNA in colorectal carcinoma. |
| Q33818673 | Higher FOXP3-TSDR demethylation rates in adjacent normal tissues in patients with colon cancer were associated with worse survival. |
| Q35962333 | Human Embryonic Stem Cell Lines with Lesions in FOXP3 and NF1. |
| Q37760416 | Human FOXP3 and cancer |
| Q39680352 | Hydroquinone-induced FOXP3-ADAM17-Lyn-Akt-p21 signaling axis promotes malignant progression of human leukemia U937 cells |
| Q26765855 | Immune Evasion Strategies of Glioblastoma |
| Q37442008 | Immune response in melanoma: an in-depth analysis of the primary tumor and corresponding sentinel lymph node |
| Q34558393 | Immunologic targeting of FOXP3 in inflammatory breast cancer cells. |
| Q35206452 | Inactivation of X-linked tumor suppressor genes in human cancer |
| Q36329777 | Increased Intraepithelial Vα24 Invariant NKT Cells in the Celiac Duodenum |
| Q84515527 | Increased number of regulatory T cells (T-regs) in the peripheral blood of patients with Her-2/neu-positive early breast cancer |
| Q37821374 | Lymphocyte subpopulation and dendritic cell phenotyping during antineoplastic therapy in human solid tumors |
| Q41048235 | Oral fibroblasts modulate the macrophage response to bacterial challenge |
| Q38811187 | Overexpression of the transcription factor FOXP3 in lung adenocarcinoma sustains malignant character by promoting G1/S transition gene CCND1. |
| Q33682262 | Oxidative stress: Biomarkers and novel therapeutic pathways |
| Q85110225 | Phenotypic and functional characterization of a CD4(+) CD25(high) FOXP3(high) regulatory T-cell population in the dog |
| Q46264331 | Prophylactic DNA vaccine targeting Foxp3(+) regulatory T cells depletes myeloid-derived suppressor cells and improves anti-melanoma immune responses in a murine model |
| Q33642321 | Prostate cancer and inflammation: the evidence |
| Q27317214 | Rapamycin Promotes Mouse 4T1 Tumor Metastasis that Can Be Reversed by a Dendritic Cell-Based Vaccine |
| Q64079593 | Regulatory T Cells and Plasmacytoid Dendritic Cells Within the Tumor Microenvironment in Gastric Cancer Are Correlated With Gastric Microbiota Dysbiosis: A Preliminary Study |
| Q58694412 | Regulatory immunotherapy in bone marrow transplantation |
| Q38172210 | Searching for the Achilles Heel of FOXP3 |
| Q42066000 | Separation of human CD4+CD39+ T cells by magnetic beads reveals two phenotypically and functionally different subsets |
| Q34176581 | Signalling through FOXP3 as an X-linked tumor suppressor. |
| Q39403986 | Significance of immunoglobulin G4 (IgG4)-positive cells in extrahepatic cholangiocarcinoma: molecular mechanism of IgG4 reaction in cancer tissue |
| Q38797446 | Silencing of Foxp3 delays the growth of murine melanomas and modifies the tumor immunosuppressive environment |
| Q39655113 | Spheres derived from the human SK-RC-42 renal cell carcinoma cell line are enriched in cancer stem cells |
| Q45935803 | Study of circulating antibodies against CD25 and FOXP3 in breast cancer. |
| Q33488520 | Systematic analysis of immune infiltrates in high-grade serous ovarian cancer reveals CD20, FoxP3 and TIA-1 as positive prognostic factors |
| Q42323672 | T regulatory cell markers in oral squamous cell carcinoma: Relationship with survival and tumor aggressiveness. |
| Q33824809 | The "O" class: crafting clinical care with FoxO transcription factors |
| Q39175905 | The Ludwig institute for cancer research Melbourne melanoma cell line panel |
| Q38029556 | The role of FOXP3 in the development and metastatic spread of breast cancer. |
| Q38540262 | The role of regulatory T cells and microglia in glioblastoma-associated immunosuppression |
| Q55430751 | The systemic evaluation and clinical significance of immunological function for advanced lung cancer patients |
| Q42517411 | The transcription factor Forkhead box P3 (FoxP3) is expressed in glioma cells and associated with increased apoptosis |
| Q37405257 | Wilms' tumor susceptibility: possible involvement of FOXP3 and CXCL12 genes. |
| Q52617295 | You, me and Foxp3: immune regulation for two. |
| Q36926211 | miR-30b/30d regulation of GalNAc transferases enhances invasion and immunosuppression during metastasis. |
Search more.